Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

5 Nov 2013 07:00

RNS Number : 1717S
Wilmington Group Plc
05 November 2013
 



5 November 2013

 

Wilmington Group plc

 

Interim Management Statement

 

 

Wilmington Group plc ("Wilmington" or "the Group"), the provider of Information, Compliance and Education to professional markets presents its Interim Management Statement for the period from 1 July 2013, based on the results for the three months ended 30 September 2013 with comments reflecting trading to date. This statement is also being made at the Group's Annual General Meeting being held today.

 

Trading UpdateGroup revenue during the three months ended 30 September 2013 was as expected marginally up on the same period in 2012, with revenues from acquisitions offset by planned disposals and discontinued marginal activities.

 

Pensions & Insurance: This division continues to deliver strong revenue and contribution growth and during the period high margins have been maintained. Inese, the provider of Spanish language subscription based publications, events and online services which was acquired in March 2013, has had a solid start to the new financial year.

 

Banking & Compliance: AMT which delivers most of its revenue and contribution during the summer months has delivered good revenue and contribution in line with our expectations, with a particularly strong performance from its graduate programmes in New York. ICT (compliance training) has continued to secure major in-house training assignments from International Banks and has a strong pipeline of projects into next year. The integration of Compliance Week, a provider of subscription based publications, events and online services which was acquired in August 2013, is progressing as planned, including the successful launch of the first Compliance Week event in Europe.

 

Healthcare: The strong performance reported by APM in France during 2013 has continued. Binley's revenues remain under pressure but overall profit contribution from the division has been maintained due to good cost control. The integration of NHiS, a provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies, which was combined with the smaller equivalent Binley's operation has progressed well.

Legal: The Legal division has continued to show a decline in turnover, reflecting planned disposals and the further scaling back of some course programmes as demand for CPD courses in the busiest time of the training year was weaker than expected. However, this revenue decline is offset to a large degree by the more flexible cost base and the continued strong performance from Bond Solon.

Business Intelligence:  As anticipated, revenue is down on the same period in the prior year, reflecting discontinued activities as a result of planned disposals and the expected decline in legacy publishing as we continue to transition from print to digital. However, contribution is in line with expectations and prior year.

 

Accountancy: As previously highlighted at the time of the full year results in September 2013, we are seeing some constraint to revenue with a decline in training revenues during the seasonally quieter first quarter. This is also reflected in the division's overall contribution due to the operational gearing of the business. We continue to invest in technical and marketing support for accountancy firms including a new responsive web platform which was launched during the period.

The Group's cash position remains robust. Net debt as at 30 September was £39.2m reflecting the acquisition of Compliance Week for £7.2m which was offset by the Group's continued strong cash generation. On 30 October 2013 a surplus freehold property was sold for £700,000 in cash and will be used to further reduce the Group's net indebtedness.

 

OutlookAt the end of the first quarter the financial performance is on track to support our expectations for the full year. July and August are typically the quietest trading months for most of the Group's businesses, the exception is AMT which delivers a significant proportion of its annual profit contribution during the first quarter. The overall trading background has not changed significantly since the full year 2013 results announcement except Legal which has had a poor end to the Legal CPD year.

 

The Group continues to invest in new technology and product development with a focus on delivering our anticipated returns from recent strategic acquisitions.

-End-

 

 

For further information, please contact:

 

Wilmington Group Plc

Charles Brady, Chief Executive

Tony Foye, Finance Director

 

FTI Consulting

Charles Palmer 

020 7422 6800

 

 

 

020 7831 3113

 

 

Notes to Editors

 

Wilmington Group plc is one of the UK's leading providers of Information, Compliance and Education for professional business markets. The Group provides business intelligence, information, training, education, events and support services for a variety of markets including the accountancy, banking, charities, financial services, healthcare, insurance, legal, and pensions sectors. Capitalised at approximately £183 million, Wilmington floated on the London Stock Exchange in 1995.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUGGCUGUPWGMC
Date   Source Headline
14th Aug 20201:38 pmRNSHolding(s) in Company
15th Jul 20202:08 pmRNSHolding(s) in Company
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
2nd Jul 20206:30 pmRNSHolding(s) in Company
2nd Jul 20206:28 pmRNSHolding(s) in Company
2nd Jul 20206:23 pmRNSHolding(s) in Company
25th Jun 20207:00 amRNSPre-close Trading Update and Banking Arrangements
28th May 202010:18 amRNSHolding(s) in Company
21st May 20204:49 pmRNSHolding(s) in Company
20th May 20204:40 pmRNSSecond Price Monitoring Extn
20th May 20204:35 pmRNSPrice Monitoring Extension
13th May 20201:47 pmRNSHolding(s) in Company
2nd Apr 20207:00 amRNSEmployee Share Ownership Trust Purchase
27th Mar 202011:14 amRNSDirector/PDMR Shareholding
26th Mar 20204:18 pmRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSUpdate on COVID-19 Coronavirus Impact and Dividend
9th Mar 202010:02 amRNSEmployee Share Ownership Trust Purchase
9th Mar 20207:00 amRNSUpdate on COVID-19 Coronavirus
3rd Mar 20208:51 amRNSTotal Voting Rights
24th Feb 20204:41 pmRNSSecond Price Monitoring Extn
24th Feb 20204:36 pmRNSPrice Monitoring Extension
20th Feb 20207:00 amRNSDirectorate Change
20th Feb 20207:00 amRNSDirectorate Change
20th Feb 20207:00 amRNSHalf-year Report
20th Feb 20207:00 amRNSHalf-year Report
13th Feb 20202:22 pmRNSEmployee Share Ownership Trust Purchase
9th Jan 20209:20 amRNSEmployee Share Ownership Trust Purchase
2nd Jan 20209:02 amRNSTotal Voting Rights
19th Dec 201910:35 amRNSEmployee Share Ownership Trust Purchase
16th Dec 20193:19 pmRNSHolding(s) in Company
6th Dec 20193:16 pmRNSHolding(s) in Company
3rd Dec 20192:40 pmRNSEmployee Share Ownership Trust Purchase
2nd Dec 201910:44 amRNSTotal Voting Rights
2nd Dec 20199:07 amRNSEmployee Share Ownership Trust Purchase
25th Nov 201910:49 amRNSHolding(s) in Company
5th Nov 201912:57 pmRNSResult of AGM
5th Nov 20197:00 amRNSAGM Statement and Q1 Trading Update
1st Nov 20197:00 amRNSTotal Voting Rights
31st Oct 20194:35 pmRNSPrice Monitoring Extension
3rd Oct 20193:48 pmRNSDirector/PDMR Shareholding
1st Oct 20193:06 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSVoting Rights and Capital
20th Sep 20193:05 pmRNSDirector/PDMR Shareholding
19th Sep 20191:37 pmRNSREPLACEMENT: Share Awards
19th Sep 201911:59 amRNSShare Awards
19th Sep 20197:00 amRNSFinancial results for the year ended 30 June 2019
2nd Sep 201910:51 amRNSVoting Rights and Capital
22nd Aug 20193:03 pmRNSHolding(s) in Company
1st Aug 20197:00 amRNSTotal Voting Rights
9th Jul 20194:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.